Search Results - "Popovici, Dorel"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Exploring the Influence of Age, Gender and Body Mass Index on Colorectal Cancer Location by Popovici, Dorel, Stanisav, Cristian, Saftescu, Sorin, Negru, Serban, Dragomir, Radu, Ciurescu, Daniel, Diaconescu, Razvan

    Published in Medicina (Kaunas, Lithuania) (30-07-2023)
    “…Background and objectives: The global burden of non-communicable diseases like obesity and cancer, particularly colorectal cancer (CRC), is increasing. The…”
    Get full text
    Journal Article
  2. 2

    Associations between Body Mass Index and Prostate Cancer: The Impact on Progression-Free Survival by Popovici, Dorel, Stanisav, Cristian, Pricop, Marius, Dragomir, Radu, Saftescu, Sorin, Ciurescu, Daniel

    Published in Medicina (Kaunas, Lithuania) (02-02-2023)
    “…This study aimed to evaluate the impact of body mass index on PCa outcomes in our institution and also to find if there are statistically significant…”
    Get full text
    Journal Article
  3. 3

    Pneumorrhachis Secondary to a Locally Advanced Rectal Cancer with Pre-Sacral Abscess-Case Report and Review by Diaconescu, Razvan, Popovici, Dorel, Tarta, Cristi, Isaic, Alexandru, Costachescu, Dan, Totolici, Bogdan

    Published in Medicina (Kaunas, Lithuania) (25-11-2023)
    “…The occurrence of pneumorrhachis (PR), defined as the presence of air within the spinal canal, presents a complex clinical picture with diverse etiological…”
    Get full text
    Journal Article
  4. 4

    Nutritional Interventions to Improve Cachexia Outcomes in Cancer—A Systematic Review by Braha, Adina, Albai, Alin, Timar, Bogdan, Negru, Șerban, Sorin, Săftescu, Roman, Deiana, Popovici, Dorel

    Published in Medicina (Kaunas, Lithuania) (21-07-2022)
    “…Background and Objectives: The prevalence of cachexia has increased across all of the cancer types and accounts for up to 20% of cancer-related deaths. This…”
    Get full text
    Journal Article
  5. 5

    Influence of Biomarkers on Mortality among Patients with Hepatic Metastasis of Colorectal Cancer Treated with FOLFOX/CAPOX and FOLFIRI/CAPIRI, Including Anti-EGFR and Anti-VEGF Therapies by Popovici, Dorel, Stanisav, Cristian, Sima, Laurentiu V, Negru, Alina, Murg, Sergiu Ioan, Carabineanu, Adrian

    Published in Medicina (Kaunas, Lithuania) (19-06-2024)
    “…Colorectal cancer is a major global health concern, with a significant increase in morbidity and mortality rates associated with metastatic stages. This study…”
    Get full text
    Journal Article
  6. 6

    What Is the Comparative Efficacy of Surgical, Endoscopic, Transanal Resection, and Radiotherapy Modalities in the Treatment of Rectal Cancer? by Isaic, Alexandru, Motofelea, Alexandru Cătălin, Costachescu, Dan, Pop, Gheorghe Nicusor, Totolici, Bogdan, Popovici, Dorel, Diaconescu, Razvan Gheorghe

    Published in Healthcare (Basel) (01-08-2023)
    “…Rectal cancer is a significant healthcare burden, and effective treatment is crucial. This research aims to compare the effectiveness of surgical and…”
    Get full text
    Journal Article
  7. 7

    Diabetes Mellitus and Other Predictors for the Successful Treatment of Metastatic Colorectal Cancer: A Retrospective Study by Roman, Deiana, Saftescu, Sorin, Timar, Bogdan, Avram, Vlad, Braha, Adina, Negru, Șerban, Bercea, Andrei, Serbulescu, Monica, Popovici, Dorel, Timar, Romulus

    Published in Medicina (Kaunas, Lithuania) (29-06-2022)
    “…Background and Objectives: In the last decades there has been an increasing body of research identifying the positive correlation between diabetes mellitus…”
    Get full text
    Journal Article
  8. 8

    Neoplasia-Associated Pericarditis-Predictor of Cancer Progression? by Boldan, Anca, Negru, Alina Gabriela, Boldan, Maria, Mazilu, Laura, Tudor, Anca, Popovici, Dorel, Săftescu, Sorin, Luca, Constantin Tudor, Negru, Șerban Mircea

    Published in Diagnostics (Basel) (02-01-2021)
    “…Pericarditis may signal the presence of cancer, even in the absence of other clinical or paraclinical signs. Corollary, the following question arises: Could…”
    Get full text
    Journal Article
  9. 9
  10. 10

    The Role of Spirituality and Religion in Improving Quality of Life and Coping Mechanisms in Cancer Patients by Nagy, Dana Sonia, Isaic, Alexandru, Motofelea, Alexandru Catalin, Popovici, Dorel Ionel, Diaconescu, Razvan Gheorghe, Negru, Serban Mircea

    Published in Healthcare (Basel) (24-11-2024)
    “…Background/Objectives: This systematic review aimed to comprehensively evaluate the role of spirituality and religion in the journey of patients with cancer…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Endurance of erythrocyte series in chemotherapy by Saftescu, Sorin, Popovici, Dorel, Oprean, Cristina, Negru, Alina, Croitoru, Adina, Zemba, Mihail, Yasar, Ionela, Preda, Maria, Negru, Serban

    Published in Experimental and therapeutic medicine (01-12-2020)
    “…Hematopoietic bone marrow toxicity is most often the limiting factor for chemotherapy doses. Increasing the intensity of chemotherapy doses (higher doses or…”
    Get full text
    Journal Article
  14. 14

    Determining factors of renal dysfunction during cisplatin chemotherapy by Săftescu, Sorin, Popovici, Dorel, Oprean, Cristina, Negru, Alina, Haiduc, Anita, Stanca, Simona, Malița, Daniel-Claudiu, Volovăț, Simona, Negru, Șerban

    Published in Experimental and therapeutic medicine (01-01-2021)
    “…Cisplatin remains one of the most active antineoplastic treatments used in oncology, being the most prestigious exponent of the golden age in chemotherapy at…”
    Get full text
    Journal Article
  15. 15

    Comparative hematological profiles for dose‑dense vs. regular anthracycline‑based neoadjuvant chemotherapy in non‑metastatic breast cancer by Popovici, Dorel, Oprean, Cristina, Saftescu, Sorin, Negru, Alina, Munteanu, Mihnea, Stanca, Horia T, Teodoru, Adrian, Stanca, Simona, Negru, Serban

    Published in Experimental and therapeutic medicine (01-07-2021)
    “…The aim of the present study was to examine both the feasibility and toxicity of neoadjuvant dose-dense chemotherapy in women with non-metastatic breast…”
    Get full text
    Journal Article
  16. 16

    Treatment Experience and Predictive Factors Associated with Response in Platinum-Resistant Recurrent Ovarian Cancer: A Retrospective Single-Institution Study by Dragomir, Radu, Sas, Ioan, Săftescu, Sorin, Popovici, Dorel, Margan, Roxana, Dragomir, Adelina Silvana, Stanca, Horia, Mocanu, Valeria, Pac, Cristina, Negru, Șerban

    Published in Journal of clinical medicine (15-08-2021)
    “…Ovarian cancer (OC) represents the most common and lethal gynecologic malignancy, due to its increased incidence and mortality rate. It is usually diagnosed in…”
    Get full text
    Journal Article
  17. 17

    Anthropometry in the immunotherapy of cutaneous and ocular melanomas by Săftescu, Sorin, Munteanu, Mihnea, Popovici, Dorel, Dragomir, Radu, Dărăbuș, Maria Diana, Negru, Alina Gabriela, Negru, Șerban Mircea

    Published in Romanian journal of ophthalmology (01-04-2020)
    “…The height of the adult individual is a balance of the expression of some genetic factors (especially the Y-M 170 haplotype of the Y chromosome) and the…”
    Get full text
    Journal Article
  18. 18

    Significance of metastatic topography for the immunotherapy of cutaneous and ocular melanomas by Săftescu, Sorin, Munteanu, Mihnea, Popovici, Dorel, Dragomir, Radu, Negru, Alina Gabriela, Pac, Patricia Cristina, Negru, Șerban Mircea

    Published in Romanian journal of ophthalmology (01-04-2020)
    “…PD-1 is expressed on the surface of activated T lymphocytes and belongs to the category of negative immune stimuli. Its blocking stimulates the immune response…”
    Get full text
    Journal Article
  19. 19

    Predictors of the response to nivolumab immunotherapy in the second or subsequent lines for metastatic non-small cell lung cancers by Săftescu, Sorin, Negru, Șerban, Volovăț, Simona, Popovici, Dorel, Chercota, Vlad, Stanca, Simona, Feier, Horea, Malita, Daniel, Dragomir, Radu, Volovăț, Constantin

    Published in Experimental and therapeutic medicine (01-06-2021)
    “…Checkpoint inhibitors represent the first therapeutic class to replace chemotherapy lines for the treatment of metastatic non-small cell lung cancer (NSCLC),…”
    Get full text
    Journal Article
  20. 20